Skip to main content
. 2023 Nov 17;11(11):1725. doi: 10.3390/vaccines11111725

Figure 4.

Figure 4

Application site appearance over time is shown for two subjects in the low-dose HD-MAP group. For Subject 05, the top application site was the MR HD-MAP. For Subject 29, the lower-left application site was the MR HD-MAP. Local responses shown were typical for the study.